The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth
Abstract
Chondroitin sulfate proteoglycans have been implicated in the regulation of cell migration and pattern formation in the developing peripheral nervous system. To identify whether the large aggregating proteoglycan versican might be mediating these processes, we prepared monospecific antibodies against a recombinant core protein fragment of chick versican. The purified antibodies recognize the pre-dominant versican splice-variants V0 and V1. Using these antibodies, we revealed a close correlation between the spacio-temporal expression of versican and the formation of molecular boundaries flanking or transiently blocking the migration pathways of neural crest cells or motor and sensory axons. Versican is present in the caudal sclerotome, the early dorsolateral tissue underneath the ectoderm, the pelvic girdle precursor and to a certain extent in the perinotochordal mesenchyme. Versican is completely absent from tissues invaded by neural crest cells and extending axons. Upon completion of neural crest cell migration and axon outgrowth, versican expression is shifted to pre-chondrogenic areas. Since versican inhibits cellular interactions with fibronectin, laminin and collagen I in vitro, the selective expression of versican within barrier tissues may be linked to a functional role of versican in the guidance of migratory neural crest cells and outgrowing axons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A series of normal stages in the development of the chick embryo
Hamburger, V., & Hamilton, H. L. (1951) · Journal of Morphology · doi:10.1002/jmor.1050880104 · Cited by 12,234
Le Douarin, N., & Kalcheim, C. (1999) · Cambridge University Press eBooks · doi:10.1017/cbo9780511897948 · Cited by 3,014
PROTEOGLYCANS: STRUCTURES AND INTERACTIONS
Kjellén, L., & Lindahl, U. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.002303 · Cited by 1,719
Proteoglycans: Structures And Interactions
Kjellen, L. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.60.1.443 · Cited by 1,594
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes
Jackson, R. L., Busch, S. J., & Cardin, A. D. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.481 · Cited by 1,094
Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro
Snow, D. M., Lemmon, V., Carrino, D. A., Caplan, A. I., & Silver, J. (1990) · Experimental Neurology · doi:10.1016/s0014-4886(05)80013-5 · Cited by 776
Proteoglycans in Cell Regulation
Ruoslahti, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80001-1 · Cited by 679
Multiple domains of the large fibroblast proteoglycan, versican.
Zimmermann, D. R., & Ruoslahti, E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08447.x · Cited by 652
Self-citationSegmentation in the vertebrate nervous system
Keynes, R. J., & Stern, C. D. (1984) · Nature · doi:10.1038/310786a0 · Cited by 436
Cited by
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Iozzo, R. V., & Murdoch, A. D. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621059 · Cited by 642
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Self-citationVersican: a versatile extracellular matrix proteoglycan in cell biology
Wight, T. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00375-7 · Cited by 562
Wang, H. U., & Anderson, D. J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81240-4 · Cited by 476
Extracellular matrix of the central nervous system: from neglect to challenge
Zimmermann, D. R., & Dours-Zimmermann, M. T. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0485-9 · Cited by 465
Self-citationChapter 22 Chondroitin sulphate proteoglycans in the CNS injury response
Morgenstern, D. A., Asher, R. A., & Fawcett, J. W. (2002) · Progress in Brain Research · doi:10.1016/s0079-6123(02)37024-9 · Cited by 419
Krull, C. E., Lansford, R., Gale, N. W., Collazo, A., Marcelle, C., Yancopoulos, G. D., Fraser, S. E., & Bronner-Fraser, M. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00256-9 · Cited by 395
Adams, J. C., & Tucker, R. P. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<280::aid-dvdy4>3.0.co;2-0 · Cited by 314
Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation
Kubo, N., Ishii, H., Xiong, X., Bianco, S., Meitinger, F., Hu, R., Hocker, J. D., Conte, M., Gorkin, D., Yu, M., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-00539-5 · Cited by 289
Hyaluronan-dependent pericellular matrix☆
EVANKO, S., TAMMI, M., TAMMI, R., & WIGHT, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.008 · Cited by 284
Role of the extracellular matrix during neural crest cell migration
Perris, R., & Perissinotto, D. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00365-8 · Cited by 269
Fidler, P. S., Schuette, K., Asher, R. A., Dobbertin, A., Thornton, S. R., Calle-Patino, Y., Muir, E., Levine, J. M., Geller, H. M., Rogers, J. H., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08778.1999 · Cited by 261
Brain derived versican V2 is a potent inhibitor of axonal growth
Schmalfeldt, M., Bandtlow, C. E., Dours-Zimmermann, M. T., Winterhalter, K. H., & Zimmermann, D. R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.5.807 · Cited by 197
Self-citationDistinct interaction of versican/PG-M with hyaluronan and link protein
Matsumoto, K., Shionyu, M., Go, M., Shimizu, K., Shinomura, T., Kimata, K., & Watanabe, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305060200 · Cited by 153
Versican V2 Assembles the Extracellular Matrix Surrounding the Nodes of Ranvier in the CNS
Dours-Zimmermann, M. T., Maurer, K., Rauch, U., Stoffel, W., Fassler, R., & Zimmermann, D. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4158-08.2009 · Cited by 123
Self-citationVersican V1 Isoform Induces Neuronal Differentiation and Promotes Neurite Outgrowth
Wu, Y., Sheng, W., Chen, L., Dong, H., Lee, V., Lu, F., Wong, C. S., Lu, W.-Y., & Yang, B. B. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0667 · Cited by 107
Gu, W.-L., Fu, S.-L., Wang, Y.-X., Li, Y., Lü, H.-Z., Xu, X.-M., & Lu, P.-H. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-128 · Cited by 80
Prenatal Diagnosis of Turner Syndrome: Report on 69 Cases
Papp, C., Beke, A., Mezei, G., Szigeti, Z., Bán, Z., & Papp, Z. (2006) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2006.25.6.711 · Cited by 74
Metadata
- Authors
- Landolt, R. M., Vaughan, L., Winterhalter, K. H., & Zimmermann, D. R.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 1995-08-01
- Volume
- 121
- Issue
- 8
- Pages
- 2303-2312
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2168876033
- Cited by
- 258
- References
- 51
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.